Number of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study / Mélanie Cogné in Annals of physical and rehabilitation medicine, Vol. 62, n°5 (Septembre 2019)

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 62, n°5 (Septembre 2019) . - p. 336-341 Titre : Number of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study Type de document : texte imprimé Auteurs : Mélanie Cogné ; Alexandre Creuzé ; Hervé Petit ; Claire Dellici ; Patrick Dehail ; Mathieu de Sèze Année de publication : 2019 Article en page(s) : p. 336-341 Note générale : doi.org/10.1016/j.rehab.2018.12.003 Langues : Anglais (eng) Mots-clés : Tennis elbow  Epicondylar tendinopathy  Botulinum toxin A  Pain  Quality of life  Gripping force Résumé : Background Epicondylar tendinopathy (“tennis elbow”) is a serious issue in manual labourers. Symptoms can persist over months or even more than 1 year, even when treated with trinitrine patches, acupuncture, sclerosis of neovessels, shock-wave therapy, autologous blood injections, platelet-rich plasma or hyaluronic acid. Botulinum toxin (BoNT-A) injections showed promising short-term results, but the long-term beneficial effects are not yet known. Objective We aimed to assess the long-term effect, side effects and recurrence rate after BoNT-A injections on chronic lateral epicondylar tendinopathy during 1 year. Methods This open study followed a 3-month randomized controlled trial. We included 50 patients followed at day 0 (V0), 90 (V1), 180–270 (V2) and 365 (V3). The main judgment criterion was the number of BoNT-A injections required to achieve pain relief with no further request for treatment by the patient. Results After one BoNT-A injection, 22/50 (44%) patients did not ask for further treatment during follow-up because of complete pain relief, and 20/50 (40%) asked for a second BoNT-A injection. For 20 patients with a second injection, 18 (90%) did not ask for further treatment during follow-up. Only 1 patient had a recurrence of pain after an initial pain relief of greater than 75%. Quality of life, and painful and maximal gripping force improved significantly at V1, V2 and V3 as compared with V0, and repercussions on daily and professional activities decreased significantly (P < 0.05). Conclusions One or 2 BoNT-A injections has favourable results for chronic epicondylar tendinopathy. Permalink : ./index.php?lvl=notice_display&id=84147 [article] Number of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study [texte imprimé] / Mélanie Cogné ; Alexandre Creuzé ; Hervé Petit ; Claire Dellici ; Patrick Dehail ; Mathieu de Sèze . - 2019 . - p. 336-341. doi.org/10.1016/j.rehab.2018.12.003 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 62, n°5 (Septembre 2019) . - p. 336-341 Mots-clés : Tennis elbow  Epicondylar tendinopathy  Botulinum toxin A  Pain  Quality of life  Gripping force Résumé : Background Epicondylar tendinopathy (“tennis elbow”) is a serious issue in manual labourers. Symptoms can persist over months or even more than 1 year, even when treated with trinitrine patches, acupuncture, sclerosis of neovessels, shock-wave therapy, autologous blood injections, platelet-rich plasma or hyaluronic acid. Botulinum toxin (BoNT-A) injections showed promising short-term results, but the long-term beneficial effects are not yet known. Objective We aimed to assess the long-term effect, side effects and recurrence rate after BoNT-A injections on chronic lateral epicondylar tendinopathy during 1 year. Methods This open study followed a 3-month randomized controlled trial. We included 50 patients followed at day 0 (V0), 90 (V1), 180–270 (V2) and 365 (V3). The main judgment criterion was the number of BoNT-A injections required to achieve pain relief with no further request for treatment by the patient. Results After one BoNT-A injection, 22/50 (44%) patients did not ask for further treatment during follow-up because of complete pain relief, and 20/50 (40%) asked for a second BoNT-A injection. For 20 patients with a second injection, 18 (90%) did not ask for further treatment during follow-up. Only 1 patient had a recurrence of pain after an initial pain relief of greater than 75%. Quality of life, and painful and maximal gripping force improved significantly at V1, V2 and V3 as compared with V0, and repercussions on daily and professional activities decreased significantly (P < 0.05). Conclusions One or 2 BoNT-A injections has favourable results for chronic epicondylar tendinopathy. Permalink : ./index.php?lvl=notice_display&id=84147

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

---

1 (1 - 1 / 1)